Neuroendocrine neoplasms (NENs) is a heterogeneous group with varying symptoms research hub

Study of Recombinant Adenovirus AdVince in Patients With Neuroendocrine Neoplasms; Safety and Efficacy (RADNET)

This study is testing a new treatment called AdVince for a type of cancer called neuroendocrine neoplasms (NENs). It's the first time this treatment is being given to people. Researchers want to see if it's safe and if it can help slow down or shrink the cancer.